Literature DB >> 11318545

Reduced free protein S levels in patients with inflammatory bowel disease: prevalence, clinical relevance, and role of anti-protein S antibodies.

S Saibeni1, M Vecchi, C Valsecchi, E M Faioni, C Razzari, R de Franchis.   

Abstract

We evaluated free plasma levels of protein S, a natural anticoagulant factor, the prevalence of anti-protein S antibodies, a possible cause of protein S deficiency, and their correlation with anti-phospholipid antibodies in 53 patients with inflammatory bowel disease (IBD) and 53 age- and sex-matched controls. Mean free plasma protein S levels (+/- SD) were significantly lower in IBD patients (0.98+/-0.32 IU/ml) than in controls (1.06+/-0.28 IU/ml) (P < 0.05); only one patient showed protein S deficiency. Specific antibodies to protein S were found in four IBD patients (7.5%) and in one control (1.9%) (P = NS). Five IBD patients (9.4%) and none of the controls showed anti-phospholipid antibodies (P < 0.06). No correlation was found between free protein S levels and anti-protein S antibodies or between anti-protein S and anti-phospholipid antibodies. In conclusion, free plasma protein S levels are slightly but significantly decreased in IBD patients. The prevalence of anti-protein S and antiphospholipid antibodies is increased in IBD patients. Anti-protein S antibodies do not appear to determine low protein S levels or to overlap with or belong to anti-phospholipid antibodies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318545     DOI: 10.1023/a:1005675921664

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis.

Authors:  A Stadnicki; J Kloczko; A Nowak; E Sierka; Z Sliwiński
Journal:  Am J Gastroenterol       Date:  1991-06       Impact factor: 10.864

2.  Vascular complications of inflammatory bowel disease.

Authors:  R W Talbot; J Heppell; R R Dozois; R W Beart
Journal:  Mayo Clin Proc       Date:  1986-02       Impact factor: 7.616

3.  Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease.

Authors:  A A Van Bodegraven; H A Tuynman; M Schoorl; A M Kruishoop; P C Bartels
Journal:  Scand J Gastroenterol       Date:  1995-06       Impact factor: 2.423

4.  High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?

Authors:  M Cattaneo; M Vecchi; M L Zighetti; S Saibeni; I Martinelli; P Omodei; P M Mannucci; R de Franchis
Journal:  Thromb Haemost       Date:  1998-10       Impact factor: 5.249

5.  Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation.

Authors:  A D'Angelo; S Vigano-D'Angelo; C T Esmon; P C Comp
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  An abnormal plasma distribution of protein S occurs in functional protein S deficiency.

Authors:  P C Comp; D Doray; D Patton; C T Esmon
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

7.  Transient protein S deficiency associated with cerebral venous thrombosis in active ulcerative colitis.

Authors:  M F Vaezi; P K Rustagi; C O Elson
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

Review 8.  Postinfectious purpura fulminans caused by an autoantibody directed against protein S.

Authors:  M Levin; B S Eley; J Louis; H Cohen; L Young; R S Heyderman
Journal:  J Pediatr       Date:  1995-09       Impact factor: 4.406

9.  Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S.

Authors:  P García de Frutos; R I Alim; Y Härdig; B Zöller; B Dahlbäck
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

10.  Deep venous thrombosis, inflammatory bowel disease, and protein S deficiency.

Authors:  E Wyshock; M Caldwell; J P Crowley
Journal:  Am J Clin Pathol       Date:  1988-11       Impact factor: 2.493

View more
  11 in total

Review 1.  Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.

Authors:  Carla V Rothlin; Jonathan A Leighton; Sourav Ghosh
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

Review 2.  Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.

Authors:  Danuta Owczarek; Dorota Cibor; Mikołaj K Głowacki; Tomasz Rodacki; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  Budd-Chiari syndrome in a patient with ulcerative colitis and no inherited coagulopathy.

Authors:  Sunil Dacha; Manjari Devidi; Evan Osmundson
Journal:  World J Hepatol       Date:  2011-06-27

4.  Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.

Authors:  Nora Sipeki; Laszlo Davida; Eszter Palyu; Istvan Altorjay; Jolan Harsfalvi; Peter Antal Szalmas; Zoltan Szabo; Gabor Veres; Zakera Shums; Gary L Norman; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

5.  International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.

Authors:  Pablo A Olivera; Stephane Zuily; Paulo G Kotze; Veronique Regnault; Sameer Al Awadhi; Peter Bossuyt; Richard B Gearry; Subrata Ghosh; Taku Kobayashi; Patrick Lacolley; Edouard Louis; Fernando Magro; Siew C Ng; Alfredo Papa; Tim Raine; Fabio V Teixeira; David T Rubin; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

6.  Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.

Authors:  Simone Saibeni; Maria J Etchevers; Dolors Tassies; Julián Panés; Joan C Reverter; Silvio Danese; Josep M Piqué; Savino Bruno; Maurizio Vecchi; Antonio Gasbarrini; Miquel Sans
Journal:  Int J Colorectal Dis       Date:  2013-04-16       Impact factor: 2.571

Review 7.  Venous thrombosis and prothrombotic factors in inflammatory bowel disease.

Authors:  Fernando Magro; João-Bruno Soares; Dália Fernandes
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  Thrombosis in inflammatory bowel diseases: what's the link?

Authors:  Martina Giannotta; Gherardo Tapete; Giacomo Emmi; Elena Silvestri; Monica Milla
Journal:  Thromb J       Date:  2015-04-02

9.  Budd-Chiari syndrome: a rare and life-threatening complication of Crohn's disease.

Authors:  Camila C Simoes; Yezaz A Ghouri; Shehzad N Merwat; Heather L Stevenson
Journal:  BMJ Case Rep       Date:  2018-01-17

10.  Cerebral venous thrombosis in a child with inflammatory bowel disease.

Authors:  Pejman Rohani; Mohsen Javadzadeh; Mitra Khalili; Reyhaneh Zojaji
Journal:  Iran J Child Neurol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.